J.J.P. Kastelein

J.J.P. Kastelein refers to the professional entity and consultancy of Professor John J.P. Kastelein, a world-renowned expert in lipidology and a prolific serial entrepreneur in the cardiovascular and metabolic disease space. Based in Amsterdam, the entity represents the academic and commercial interests of Dr. Kastelein, who has been a foundational figure in companies such as uniQure, Dezima Pharma, and NewAmsterdam Pharma. The consultancy provides strategic expertise in the development of novel therapies for dyslipidemia, including CETP inhibitors and gene therapies. Dr. Kastelein is widely recognized as a leading Key Opinion Leader (KOL) who has designed and executed numerous pivotal clinical trials for major pharmaceutical companies. His work has significantly advanced the treatment of atherosclerosis and inherited lipid disorders.